7:30 - 8:00 AM

Registration & Continental Breakfast

8:00 - 8:15 AM

Welcome

8:15 - 9:30 AM

Paper Session I
Moderator: Michael J. Gooodheart, MD

01: Trends in Research Productivity Among Incoming Gynecologic Oncology Fellows
Monica Janke, MD, University of Michigan

02: Gynecology Oncology Adnexal Mass Referral Patterns
Rusha Bajpai, MD, University of Wisconsin

03: Does Cytomegalovirus Infection Play a Role in Patient-reported Symptoms of ‘Chemo Brain’ and Neuropathy in Ovarian Cancer Survivors?
Xuan Li, MD, University of Minnesota

04: An Alternative to Excision: Use of Trichloroacetic Acid for Management of High Grade Cervical Dysplasia in Young Women
Sadhvi Batra, MD, MPH, University of Michigan

05: Pilomatrix-like High-grade Endometrioid Carcinoma (PiMHEC): A Recently Described Under-recognized and Highly Aggressive Variant of Endometrioid Carcinoma
Paul Weisman, MD, University of Wisconsin

9:30 - 9:45 AM

Break & Exhibits

9:45 - 11:00 AM

Paper Session II
Moderator: Radhika Gogoi, MD, PhD

06: Interferon-stimulated Gene Signature Differentiates Immune Resistant and Immune Sensitive Ovarian Cancers
Danielle Arias, MD, MPH, Mercy Hospital St. Louis/Wayne State University

07: A Natural Language Processing Method Identifies an Association Between Bacterial Communities in the Upper Genital Tract and Ovarian Cancer
Andrew Polio, MD, University of Iowa

08: Predicting Clinical Outcomes in Ovarian Cancer with Deep Learning Analysis of Histopathology Slides
Katherine Sawaya, MD, University of Iowa

09: Validation of NGS-based Comprehensive Genomic Profiling (CGP) for the Molecular Classification of Endometrial Carcinomas (EMCA) Into Prognostic Subgroups
Julia Elvin, MD, PhD, Foundation Medicine, Inc.

10: Genomic, Transcriptomic, and Epigenetic Characterization of Mucinous Adenocarcinoma of the Cervix
Susan Duyar-Ayerdi, MD, MA, Medical College of Wisconsin

11:00 AM -
12:00 PM

Keynote Address
Addressing Cancer Disparities in the Northern Plains American Indians: A Community Based NCI Funded Program
Daniel Petereit, MD, FASTRO, Rapid City Regional Hospital/Monument Health

12:00 - 12:45 PM

Industry Sponsored Lunch Symposium 
Addressing Unmet Needs in Platinum-Resistant Ovarian Cancer
Amina Ahmed, MD, Cancer Center Director at RUSH-MD Anderson

Sponsored by: Immunogen

**This lunch is paid for by HAGO and your attendance will not trigger Sunshine Act reporting.

12:45 - 2:15 PM

Paper Session III
Moderator: Jamie Bakkum-Gamez, MD

11: Cervical Cancer 2010-2019: South Dakota Catchment of 40,000 Square Miles
Samanta Metzger, MD, University of Iowa

12: Racial Disparities in Financial Toxicity and Social Risks among Detroit Endometrial Cancer Survivors
Kaitlin Burchett, MD, Wayne State University/Detroit Medical Center

13: Cardiovascular Disease Contributes to Endometrial Cancer Outcome Disparities for Black Women
Mitchell Depke, MD, Medical College of Wisconsin

14: A Comparison of Adjuvant Therapy Modality and Treatment Outcomes Between Appalachian and Non-Appalachian Patients with High-Risk Endometrial Carcinoma
Josie Llanora, MD, University of Michigan

15: Progression-Free Survival as a Surrogate End Point of Overall Survival in Randomized Controlled Trials of Ovarian Cancer Maintenance Therapies
Matt Wagar, MD, University of Wisconsin

16: Psychosocial Support Needs of Rural Cancer Survivors in Minnesota
Morgan Gruner, MD, University of Minnesota

2:15 - 2:50 PM

Exhibits & Break

2:50 - 4:00 PM

Controversies in Practice
Moderator:  Stephen Rose, MD

Topic 1: Simple vs. Radical Hysterectomy for Early Cervical Cancer
Topic 2: Primary vs. Interval Cytoreduction for Ovarian Cancer

4:00 - 4:30 PM

Exhibits

Diagnosis, Management, and Outcomes in Serous Endometrial Intraepithelial Carcinoma (SEIC)
Susan Duyar-Ayerdi, MD, MA, Medical College of Wisconsin

Postoperative Readmission Rates for Patients with Advanced Epithelial Ovarian Cancer after Primary vs. Interval Debulking Surgery
Alexandra Samborski, MD, University of Tennessee 

Incidental Serous Tubal Intraepithelial Carcinoma Finding in a Nepalese Patient Undergoing Opportunistic Salpingectomy and the Discovery of a BRCA1 Pathogenic Variant
Kristin Tischer, MD, Mayo Clinic

Gynecologic Oncology Robotic Hysterectomy Same Day Discharge (SDD) Reaches CMS “Triple Aim” in Large Community Hospital Setting
Isabella Zent, MS-2, Creighton University